Publications

SAFETY AND EFFICACY OF INTRAVESICAL ADMINISTRATION FOR SYMPTOM CONTROL IN CHRONIC CYSTOPATHY

INTRODUCTION: Chronic cystopathy is a widespread pathology. Intravesical hyaluronic acid (instillation) is one of the treatment options for cystopathies. This study analyzed safety and efficacy of intravesical hyaluronic acid instillations in patients with symptoms of urinary blabber disease.

(more…)

Intravesical instillations of high molecular weight sodium hyaluronate in radiation cystitis

Intravesical instillation of high molecular weight sodium hyaluronate in radiation‑induced cystitis: a prospective pilot study

Purpose. To assess the efficacy and safety of intravesical instillation of high molecular weight sodium hyaluronate (HMW- HA) for the treatment of radiation-induced cystitis.

(more…)


SELF-MEDICATION CAN BE HARMFUL TO YOUR HEALTH

Before using the product offered on this information resource, it is recommended to consult your doctor and read the instructions.

Information about medical products for the professional work of health professionals. INSTYLAN (INSTILAN) 0.16% colorless, transparent, viscous gel of hyaluronic acid of non-animal origin, sterile, physiological pH.

INSTYLAN 0,16% approved as Class ІІa medical devices. EU Declaration of Conformity. Registration number: DD 60107286 0001 Manufacturer: Diaco Biofarmaceutici S.R.L. Via Flavia 124, 34147, Trieste, Italy. E-mail: info@diaco.it. www.diaco.it.

ACCESS FOR HEALTHCARE PROFESSIONALS
If you are a healthcare professional, please confirm it by clicking the "ENTER" button in order to start work.